Papivax Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Papivax General Information

Description

Provider of immunotherapies. The company provides therapies for the prevention of human papillomavirus (HPV).

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare
Primary Office
  • 645 Baltimore Annapolis
  • Severna Park, MD 21146
  • United States
+1 (301) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Papivax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Grant 01-Jun-2014 00000 Completed Generating Revenue
To view Papivax’s complete valuation and funding history, request access »

Papivax Executive Team (1)

Name Title Board Seat Contact Info
Yung-Nien Chang Ph.D Chief Scientific Officer
To view Papivax’s complete executive team members history, request access »

Papivax Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Papivax Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Papivax’s complete investors history, request access »